Charles River Laboratories International, Inc. (CRL)
226.90
+8.71
(+3.99%)
USD |
NYSE |
Jan 21, 16:00
228.56
+1.66
(+0.73%)
After-Hours: 20:00
Charles River Laboratories International EPS Diluted (Quarterly): 1.101 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Johnson & Johnson | 2.121 |
| UnitedHealth Group, Inc. | 2.586 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 55.56M |
| Revenue (Quarterly) | 1.005B |
| Total Expenses (Quarterly) | 950.43M |
| Enterprise Value | 13.21B |
| Gross Profit Margin (Quarterly) | 32.32% |
| Profit Margin (Quarterly) | 5.53% |
| Earnings Yield | -0.69% |
| Operating Earnings Yield | 4.22% |
| Normalized Earnings Yield | 1.503 |